Clinical trial

Neocartilage Implant to Treat Cartilage Lesions of the Knee

NCT01400607 · ISTO Technologies, Inc., Industry · Terminated

Key facts

NCT number NCT01400607
Title Neocartilage Implant to Treat Cartilage Lesions of the Knee
Official title Randomized Controlled Trial to Evaluate the Efficacy of a Neocartilage Implant in the Management of ICRS Grade 3 to 4 Articular Cartilage Lesions of the Knee
Lead sponsor ISTO Technologies, Inc., Industry
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Articular Cartilage Disorder, Degeneration, Articular Cartilage, Chronic Cartilage Injury, Acute Cartilage Injury, Defect of Articular Cartilage
Intervention type Biological, Other
Interventions Neocartilage Implant/DeNovo® ET (Engineered Tissue Graft), Microfracture
Enrollment 14
Start date Jul 1, 2011
Primary completion Sep 1, 2020
Completion Sep 1, 2020
First posted Jul 22, 2011
Last update posted Aug 31, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies